切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2018, Vol. 07 ›› Issue (02) : 138 -142. doi: 10.3877/cma.j.issn.2095-3232.2018.02.013

所属专题: 文献

临床研究

术后预后营养指数在肝细胞癌患者预后中的价值
梁荣朴1, 叶林森1, 张杰滨1, 汪国营1, 陈规划1,()   
  1. 1. 510630 广州,中山大学附属第三医院肝脏外科暨肝移植中心 中山大学器官移植研究所 广东省器官移植研究中心
  • 收稿日期:2017-11-18 出版日期:2018-04-10
  • 通信作者: 陈规划
  • 基金资助:
    广东省科技计划项目(2017B020209004,2017B020169013); 广州市科技计划项目(201604020001,2014B020228003,201508020262)

Value of postoperative prognostic nutritional index in prognosis of patients with hepatocellular carcinoma

Rongpu Liang1, Linsen Ye1, Jiebin Zhang1, Guoying Wang1, Guihua Chen1,()   

  1. 1. Department of Hepatic Surgery and Liver Transplantation Center, the Third Affiliated Hospital of Sun Yat-sen University; Organ Transplantation Institue of Sun Yat-sen Univesity; Organ Transplantation Research Center of Guangdong Province, Guangzhou 510630, China
  • Received:2017-11-18 Published:2018-04-10
  • Corresponding author: Guihua Chen
  • About author:
    Corresponding author: Chen Guihua, Email:
引用本文:

梁荣朴, 叶林森, 张杰滨, 汪国营, 陈规划. 术后预后营养指数在肝细胞癌患者预后中的价值[J/OL]. 中华肝脏外科手术学电子杂志, 2018, 07(02): 138-142.

Rongpu Liang, Linsen Ye, Jiebin Zhang, Guoying Wang, Guihua Chen. Value of postoperative prognostic nutritional index in prognosis of patients with hepatocellular carcinoma[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2018, 07(02): 138-142.

目的

探讨术后预后营养指数(post-PNI)在肝细胞癌(肝癌)肝切除患者预后中的价值。

方法

回顾性分析2009年1月至2014年12月在中山大学附属第三医院行肝癌肝切除的316例患者临床资料。其中男289例,女27例;平均年龄(50±12)岁。患者均签署知情同意书,符合医学伦理学规定。采用患者术后第一次检查的ALB及淋巴细胞计数计算post-PNI。根据受试者工作特征(ROC)曲线确定post-PNI的最佳截断值,将患者分为高post-PNI组及低post-PNI组。两组生存分析采用Kaplan-Meier法和Log-rank检验,Cox比例风险模型评估生存预后的因素影响。

结果

ROC曲线决定post-PNI最佳截断值为36.4。高post-PNI组165例,低post-PNI组151例。高post-PNI组1、3、5年无复发生存率和总体生存率分别为74.4%、55.5%、50.3%和93.8%、85.9%、78.7%,低post-PNI组相应为60.9%、32.5%、27.1%和91.3%、72.0%、62.9%,差异有统计学意义(χ2=16.939,8.428;P<0.05)。多因素分析显示post-PNI≤36.4是肝癌肝切除患者无复发生存和总体生存的独立危险因素(HR=1.705,1.771;P<0.05)。

结论

post-PNI是肝癌肝切除患者无复发生存和总体生存的独立影响因素,低post-PNI患者预后差。

Objective

To explore the value of postoperative prognostic nutritional index (post-PNI) in the prognosis of patients with hepatocellular carcinoma (HCC) after hepatectomy.

Methods

Clinical data of 316 patients receiving HCC hepatectomy in the Third Affiliated Hospital of Sun Yat-sen University between January 2009 and December 2014 was analyzed retrospectively. There were 289 males and 27 females, with a mean age of (50±12) years. The informed consents of all patients were obtained and the local ethical committee approval was received. Post-PNI was calculated using value of ALB and lymphocyte count of the first examination after operation. The optimum cut-off value of post-PNI was defined according to receivers' operating characteristic (ROC) curve, and the patients were divided into high post-PNI group and low post-PNI group. Survival analysis of two groups was conducted using Kaplan-Meier method and Log-rank test, and the influencing factors for survival and prognosis were analyzed by Cox proportional hazard model.

Results

The optimum cut-off value of post-PNI was 36.4 by ROC curve. There were 165 cases in high post-PNI group, and 151 cases in low post-PNI group. The 1-, 3- and 5-year recurrence-free survival rate and overall survival rate of the high post-PNI group were respectively 74.4%, 55.5%, 50.3% and 93.8%, 85.9%, 78.7%, and were respectively 60.9%, 32.5%, 27.1% and 91.3%, 72.0% and 62.9% in low post-PNI group were, where significant differences were observed (χ2=16.939, 8.428; P<0.05). Multiple-factor analysis showed that post-PNI≤36.4 was the independent risk factor for the recurrence-free survival and overall survival of HCC hepatectomy patients (HR=1.705, 1.771; P<0.05).

Conclusions

Post-PNI is an influencing factor for the recurrence-free survival and overall survival of HCC hepatectomy patients. Low post-PNI patients have worse prognosis.

图1 316例肝癌肝切除患者术后预后营养指数的受试者工作特征(ROC)曲线图
图2 316例肝癌肝切除患者术后Kaplan-Meier生存曲线
表1 肝癌肝切除患者术后预后的Cox比例风险模型多因素分析
[1]
El-Serag HB. Hepatocellular carcinoma[J]. N Engl J Med, 2011, 365(12):1118-1127.
[2]
Zhong JH, Ma L, Li LQ. Postoperative therapy options for hepatocellular carcinoma[J]. Scand J Gastroenterol, 2014, 49(6):649-661.
[3]
Poon RT, Ng IO, Fan ST, et al. Clinicopathologic features of long-term survivors and disease-free survivors after resection of hepatocellular carcinoma:a study of a prospective cohort[J]. J Clin Oncol, 2001, 19(12):3037-3044.
[4]
Zhong JH, Li H, Li LQ, et al. Adjuvant therapy options following curative treatment of hepatocellular carcinoma:a systematic review of randomized trials[J]. Eur J Surg Oncol, 2012, 38(4):286-295.
[5]
Barreto Penié J, Cuban Group for the Study of Hospital Malnutrition. State of malnutrition in Cuban hospitals[J]. Nutrition, 2005, 21(4):487-497.
[6]
Andreoli A, De Lorenzo A, Cadeddu F, et al. New trends in nutritional status assessment of cancer patients[J]. Eur Rev Med Pharmacol Sci, 2011, 15(5):469-480.
[7]
Onodera T, Goseki N, Kosaki G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients[J]. Nihon Geka Gakkai Zasshi, 1984, 85(9):1001-1005.
[8]
Jiang N, Deng JY, Ding XW, et al. Prognostic nutritional index predicts postoperative complications and long-term outcomes of gastric cancer[J]. World J Gastroenterol, 2014, 20(30):10537-10544.
[9]
Tokunaga R, Sakamoto Y, Nakagawa S, et al. Prognostic nutritional index predicts severe complications, recurrence, and poor prognosis in patients with colorectal cancer undergoing primary tumor resection[J]. Dis Colon Rectum, 2015, 58(11):1048-1057.
[10]
Feng JF, Chen QX. Significance of the prognostic nutritional index in patients with esophageal squamous cell carcinoma[J]. Ther Clin Risk Manag, 2014(10):1-7.
[11]
Yao ZH, Tian GY, Wan YY, et al. Prognostic nutritional index predicts outcomes of malignant pleural mesothelioma[J]. J Cancer Res Clin Oncol, 2013, 139(12):2117-2123.
[12]
Geng Y, Qi Q, Sun M, et al. Prognostic nutritional index predicts survival and correlates with systemic inflammatory response in advanced pancreatic cancer[J]. Eur J Surg Oncol, 2015, 41(11):1508-1514.
[13]
Zhang X, Li C, Wen T, et al. Postoperative prognostic nutritional index predicts survival of patients with hepatocellular carcinoma within Milan criteria and hypersplenism[J]. J Gastrointest Surg, 2017, 21(10):1626-1634.
[14]
Omata M, Lesmana LA, Tateishi R, et al. Asian pacific association for the study of the liver consensus recommendations on hepatocellular carcinoma[J]. Hepatol Int, 2010, 4(2):439-474.
[15]
Chen KL, Liu YH, Li WY, et al. The prognostic nutritional index predicts survival for patients with extranodal natural killer/T cell lymphoma, nasal type[J]. Ann Hematol, 2015, 94(8):1389-1400.
[16]
Watanabe M, Iwatsuki M, Iwagami S, et al. Prognostic nutritional index predicts outcomes of gastrectomy in the elderly[J]. World J Surg, 2012, 36(7):1632-1639.
[17]
Chan AW, Chan SL, Wong GL, et al. Prognostic nutritional index (PNI) predicts tumor recurrence of very early/early stage hepatocellular carcinoma after surgical resection[J]. Ann Surg Oncol, 2015, 22(13):4138-4148.
[18]
Ke M, Xu T, Li N, et al. Prognostic nutritional index predicts short-term outcomes after liver resection for hepatocellular carcinoma within the Milan criteria[J]. Oncotarget, 2016, 7(49):81611-81620.
[19]
Okamura Y, Sugiura T, Ito T, et al. The optimal cut-off value of the preoperative prognostic nutritional index for the survival differs according to the TNM stage in hepatocellular carcinoma[J]. Surg Today, 2017, 47(8):986-993.
[20]
Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting[J]. Immunity, 2004, 21(2):137-148.
[21]
Wu SJ, Lin YX, Ye H, et al. Lymphocyte to monocyte ratio and prognostic nutritional index predict survival outcomes of hepatitis B virus-associated hepatocellular carcinoma patients after curative hepatectomy[J]. J Surg Oncol, 2016, 114(2):202-210.
[22]
Lin ZX, Ruan DY, Li Y, et al. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection[J]. World J Gastroenterol, 2015, 21(38):10898-10906.
[23]
Li X, Chen ZH, Xing YF, et al. Platelet-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma[J]. Tumour Biol, 2015, 36(4):2263-2269.
[24]
Limaye AR, Clark V, Soldevila-Pico C, et al. Neutrophil-lymphocyte ratio predicts overall and recurrence-free survival after liver transplantation for hepatocellular carcinoma[J]. Hepatol Res, 2013, 43(7):757-764.
[1] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[2] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[3] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[4] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[5] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[6] 冯旺, 马振中, 汤林花. CT扫描三维重建在肝内胆管细胞癌腹腔镜肝切除术中的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 104-107.
[7] 赖全友, 高远, 汪建林, 屈士斌, 魏丹, 彭伟. 三维重建技术结合腹腔镜精准肝切除术对肝癌患者术后CD4+、CD8+及免疫球蛋白水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 651-654.
[8] 唐梅, 周丽, 牛岑月, 周小童, 王倩. ICG荧光导航的腹腔镜肝切除术临床意义[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 655-658.
[9] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[10] 顾雯, 凌守鑫, 唐海利, 甘雪梅. 两种不同手术入路在甲状腺乳头状癌患者开放性根治性术中的应用比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 687-690.
[11] 叶劲松, 刘驳强, 柳胜君, 吴浩然. 腹腔镜肝Ⅶ+Ⅷ段背侧段切除[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 315-315.
[12] 郭兵, 王万里, 何凯, 黄汉生. 腹腔镜下肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 143-143.
[13] 魏丽霞, 张安澜, 周宝勇, 李明. 腹腔镜下Ⅲb型肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 145-145.
[14] 董佳, 王坤, 张莉. 预后营养指数结合免疫球蛋白、血糖及甲胎蛋白对HBV 相关慢加急性肝衰竭患者治疗后预后不良的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 555-559.
[15] 王景明, 王磊, 许小多, 邢文强, 张兆岩, 黄伟敏. 腰椎椎旁肌的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 846-852.
阅读次数
全文


摘要